E-7046 (Cat No.:I011760) is a selective antagonist of the prostaglandin E2 (PGE2) receptor EP4 subtype. It functions by blocking the binding of PGE2 to the EP4 receptor, thereby inhibiting the downstream signaling pathways activated by EP4 receptor activation. By antagonizing EP4, E-7046 has demonstrated anti-inflammatory effects and has shown potential therapeutic applications in various inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease. Additionally, E-7046 has also been investigated for its potential anti-tumor activity, as EP4 signaling is implicated in promoting tumor growth and progression.
Catalog Number | I011760 |
CAS Number | 1369489-71-3 |
Synonyms | 4-[(1S)-1-[[[3-(difluoromethyl)-1-methyl-5-[3-(trifluoromethyl)phenoxy]-1H-pyrazol-4-yl]carbonyl]amino]ethyl]-benzoic acid |
Molecular Formula | C₂₂H₁₈F₅N₃O₄ |
Purity | ≥95% |
Target | Prostaglandin Receptor |
Solubility | Soluble in DMSO |
Storage | Store at -20°C |
IUPAC Name | 4-[(1S)-1-[[3-(difluoromethyl)-1-methyl-5-[3-(trifluoromethyl)phenoxy]pyrazole-4-carbonyl]amino]ethyl]benzoic acid |
InChI | InChI=1S/C22H18F5N3O4/c1-11(12-6-8-13(9-7-12)21(32)33)28-19(31)16-17(18(23)24)29-30(2)20(16)34-15-5-3-4-14(10-15)22(25,26)27/h3-11,18H,1-2H3,(H,28,31)(H,32,33)/t11-/m0/s1 |
InChIKey | MKLKAQMPKHNQPR-NSHDSACASA-N |
SMILES | C[C@@H](C1=CC=C(C=C1)C(=O)O)NC(=O)C2=C(N(N=C2C(F)F)C)OC3=CC=CC(=C3)C(F)(F)F |
Reference | 1. Oncoimmunology. 2017 Jun 28;6(8):e1338239. doi: 10.1080/2162402X.2017.1338239. |